NovoCure(MX:NVCRN)
MX$248.490.00 (0.00%)
MX:NVCRN
NovoCure earnings date
MX$248.49
At close:0.00 (0.00%)
NovoCure (NVCRN) Q2 2018 Earnings Report
1 Followers
MX:NVCRN Q2 2018 EPS Results
- Actual EPS
- -MXN 3.16
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -MXN 4.46
MX:NVCRN Q2 2018 Revenue Results
- Actual Revenue
- MXN 1.14B
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2018
- Date
- 07/26/2018
- Time
- TBA
- Conference Call
- Thursday, July 26, 2018
MX:NVCRN Upcoming Earnings
NovoCure's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q2 2018 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2018 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2018 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:NVCRN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | -4.00- | -4.09 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | -4.37-1.67 | -6.13 | 72.73% (+4.46) | |
| Jul 23, 2026 | 2026 (Q2) | -6.17-2.42 | -6.69 | 63.89% (+4.28) | |
| Apr 30, 2026 | 2026 (Q1) | -9.52-11.53 | -5.76 | -100.00% (-5.76) | |
| Feb 26, 2026 | 2025 (Q4) | -7.64-4.09 | -11.34 | 63.93% (+7.25) | |
| Oct 30, 2025 | 2025 (Q3) | -7.81-6.13 | -5.21 | -17.86% (-0.93) | |
| Jul 24, 2025 | 2025 (Q2) | -7.14-6.69 | -5.76 | -16.13% (-0.93) | |
| Apr 24, 2025 | 2025 (Q1) | -8.63-5.76 | -6.69 | 13.89% (+0.93) | |
| Feb 27, 2025 | 2024 (Q4) | -6.39-11.34 | -8.37 | -35.56% (-2.97) | |
| Oct 30, 2024 | 2024 (Q3) | -6.21-5.21 | -8.55 | 39.13% (+3.35) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
